The Battle for Generic Drug Quality — On September 9, 2020 Katherine Eban, New York Times bestselling author of Bottle of Lies, and Joe Graedon, founder, editor and podcast host of The People’s Pharmacy, joined Valisure founder and CEO David Light to discuss how the pervasive issues with overseas drug manufacturing, fraud, and limitations of government oversight have put the American drug supply and consumers at risk.
The Battle for Generic Drug Quality — On September 9, 2020 Katherine Eban, New York Times bestselling author of Bottle of Lies, and Joe Graedon, founder, editor and podcast host of The People’s Pharmacy, joined Valisure founder and CEO David Light to discuss how the pervasive issues with overseas drug manufacturing, fraud, and limitations of government oversight have put the American drug supply and consumers at risk.
The Battle for Generic Drug Quality — On September 9, 2020 Katherine Eban, New York Times bestselling author of Bottle of Lies, and Joe Graedon, founder, editor and podcast host of The People’s Pharmacy, joined Valisure founder and CEO David Light to discuss how the pervasive issues with overseas drug manufacturing, fraud, and limitations of government oversight have put the American drug supply and consumers at risk.
The Battle for Generic Drug Quality — On September 9, 2020 Katherine Eban, New York Times bestselling author of Bottle of Lies, and Joe Graedon, founder, editor and podcast host of The People’s Pharmacy, joined Valisure founder and CEO David Light to discuss how the pervasive issues with overseas drug manufacturing, fraud, and limitations of government oversight have put the American drug supply and consumers at risk.
